Sort
51,593 grants matching “hepatitis”
Control of Viral Pathogenesis by Regulation of 2-5A Levels
$704,472Susan R. Weiss · University Of Pennsylvania · R01 · FY2014 · AI
Infant immunoprophylaxis against a primate lentivirus
$704,456Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · R37 · FY2007 · AI
Vitamin E Pharmacokinetics And Biomarkers In Normal And Obese Women
$704,429Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States
$704,354Xuehong Zhang · Brigham And Women'S Hospital · U01 · FY2023 · CA
Organogenesis of Ectopic Tissue in Lymph Node
$704,330Eric Lagasse · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · DK
Organogenesis of Ectopic Tissue in Lymph Node
$704,330Eric Lagasse · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DK
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
$704,322Karen K Miller · Massachusetts General Hospital · R01 · FY2024 · DK
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
$704,301Jordan E Lake · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · DK
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics
$704,221Sonia Michael Najjar · Ohio University Athens · R01 · FY2020 · MD
Enhancing immune regulation in gene therapy for hemophilia
$704,157Roland W. Herzog · Indiana University Indianapolis · R01 · FY2024 · HL
Plant-derived vaccines against hepatitis C Cooperative *
$704,052Charles Joel Arntzen · Arizona State University-Tempe Campus · U19 · FY2006 · AI
Biochemistry and Genetics of Hepatocarcinogenesis
$704,036Christopher A Bradfield · University Of Wisconsin-Madison · P01 · FY2007 · CA
Impact of Drug Policy Reform on the HIV Risk Environment among IDUs in Tijuana
$703,997Steffanie A Strathdee · University Of California, San Diego · R37 · FY2016 · DA
CVD in American Indians Biomarker lab and Arizona Field Center
$703,961Barbara V Howard · Medstar Health Research Institute · R01 · FY2014 · HL
Hepatitis C Pathogenesis and the Human Genome
$703,933David L Thomas · Johns Hopkins University · R01 · FY2011 · DA
The Progression of Hepatitis C Among IDUs with HIV
$703,923Ashwin Balagopal · Johns Hopkins University · R01 · FY2015 · DA
Statin Therapy for patients with compensated Cirrhosis
$703,876Elliot Tapper · University Of Michigan At Ann Arbor · U01 · FY2023 · DK
Analysis of immunity, viral adaptation and pathogenesis in a new mouse model of HCV-related rodent hepacivirus infection
$703,869Charles M. Rice · Rockefeller University · R01 · FY2017 · AI
Identification and Characterization of Loci Associated with Non-alcoholic Fatty Liver Disease
$703,773Nicholette D. Allred · Wake Forest University Health Sciences · R01 · FY2021 · DK
MECHANISMS OF CHRONIC HEPATITIS B INFECTION
$703,710Vaccine Research Institute Of San Diego · R01 · FY2005 · AI
Investigating the role of frailty on outcomes in acutely ill patients with cirrhosis undergoing liver transplantation in the acute care setting
$703,640Jennifer C. Lai · University Of California, San Francisco · R01 · FY2025 · DK
HIV Disease Outcomes in Drug Users in Clinical Practice
$703,568Richard Douglas Moore · Johns Hopkins University · R01 · FY2009 · DA
CLINICAL IMPACT ON HCV &ALCOHOL IN HIV INFECTED PERSONS
$703,528Boston Medical Center · R01 · FY2004 · AA
HCV Genomic Variability in HIV Infected Hemophiliacs
$703,465University Of Cincinnati · R01 · FY2003 · AI
Natural history, risk prediction and cost of cirrhosis in insured Americans.
$703,454Daniela P Ladner · Northwestern University At Chicago · R01 · FY2022 · DK